VAGINAL PESSARY MARKET ANALYSIS

Global vaginal pessary market is estimated to be valued at USD 356.4 Mn in 2023, and exhibit a compound annual growth rate (CAGR) of 10% during the forecast period from 2023 to 2030. By 2030, the market is projected to reach a value of USD 693.8 Mn . This growth is primarily driven by factors such as the increasing prevalence of pelvic organ prolapse and stress urinary incontinence, and rising number of elderly individuals, who are prone to pelvic organ prolapse.

The demand for non-invasive treatment options for these conditions is also on the rise globally, which is expected to further contribute to the growth of the global vaginal pessary market during the forecast period from 2022 to 2030. These factors are combined with the growing awareness and availability of vaginal pessaries is a viable treatment option, which are expected to propel market expansion in the near future.

Global Vaginal Pessary Market Regional Insights

• North America: In 2022, North America held a significant share in the global vaginal pessary market. The region's market growth is due to factors such as the presence of advanced healthcare infrastructure, high awareness about pelvic organ prolapse and stress urinary incontinence, and the availability of technologically advanced medical devices. A large geriatric population and increasing demand for non-invasive treatment options contribute to the market growth in this region.
• Europe: Europe is another prominent market for vaginal pessaries. The region's market growth is driven by factors such as a high prevalence of pelvic organ prolapses and stress urinary incontinence among women, increasing healthcare expenditure, and favorable reimbursement policies. The presence of key market players and ongoing research and development (R&D) activities further contribute to the market growth in Europe.
• Asia Pacific: The vaginal pessary market in Asia Pacific is expected to witness significant growth during the forecast period. This growth is due to factors such as a large population base, increasing awareness about pelvic floor disorders, and rising healthcare expenditure. Moreover, the growing adoption of advanced medical technologies and the expansion of healthcare infrastructure in countries like China and India are likely to fuel market growth in this region.

Figure 1. Global Vaginal Pessary Market Share (%), by Region, 2023

To learn more about this report, request a free sample copy

Analyst View: Global vaginal pessary market is poised for significant growth in the coming years. This growth is primarily driven by the increasing prevalence of conditions such as pelvic organ prolapse and urinary incontinence, particularly among the aging female population. The market is also benefiting from the growing awareness about non-surgical treatment options for these conditions. Vaginal pessaries, being non-invasive and cost-effective, are becoming a preferred choice for many women. The ability of these devices to improve the quality of life by managing symptoms effectively is further contributing to their adoption. However, the market also faces challenges such as lack of awareness in some regions, and cultural and social stigma associated with conditions like pelvic organ prolapse. These factors can hinder the market growth to some extent. Despite these challenges, increasing government initiatives aimed at improving women's health, along with advancements in product design and material, present significant opportunities for market expansion. In conclusion, the outlook for the global vaginal pessary market is positive, with potential for substantial growth driven by increasing prevalence of target conditions, growing awareness, and ongoing product advancements.

Global Vaginal Pessary Market Drivers:

• Increasing prevalence of pelvic organ prolapse and stress urinary incontinence: Growing prevalence of pelvic organ prolapse and stress urinary incontinence among women is a significant driver for the vaginal pessary market. These conditions affect a large number of women worldwide, thus creating a demand for effective treatment options such as vaginal pessaries. For instance, in April 2022, according to article published in UpToDate, an electronic clinical resource tool between 15-% -80%  of women with pelvic floor dysfunction also have stress urinary incontinence (SUI) and pelvic organ prolapse (POP).
• Awareness and education: Increasing awareness about pelvic floor disorders and the availability of treatment options such as vaginal pessaries are driving the market growth of the global vaginal pessary market. Educational campaigns, initiatives by healthcare organizations, and awareness programs contribute in improving understanding and recognition of these conditions, thus leading to increased demand for treatment options.
• Rising geriatric population: The global increase in the geriatric population, who are more prone to pelvic organ prolapse, contributes to the growth of the global vaginal pessary market. As the elderly population continues to grow, the demand for treatment options to manage pelvic floor disorders is expected to rise thus the driving market growth.
• Non-invasive treatment preference: There is a growing preference for non-invasive treatment options among patients. Vaginal pessaries provide a non-invasive approach to manage pelvic organ prolapse and stress urinary incontinence, thereby avoiding the need for surgery. The demand for non-invasive treatments is increasing, which positively impacts the market growth of vaginal pessaries.

Global Vaginal Pessary Market Opportunities:

• Increasing Government Opportunities: Increasing government initiatives present a significant opportunity for the vaginal pessaries market. Governments across various regions are taking proactive steps to improve women's health and are investing in healthcare infrastructure, which includes the provision of advanced medical devices such as vaginal pessaries. In January 2021, as part of combination prevention measures, the World Health Organization suggested that women at substantial risk of HIV (human immunodeficiency virus) infection be given the option to choose the dapivirine vaginal ring (DPV-VR) as an extra preventive measure.
• Emerging markets: There is significant potential for market growth in emerging economies. Rapidly developing healthcare infrastructure, increasing disposable income, and improving healthcare awareness in countries across Asia, Latin America, and Africa present untapped opportunities for market expansion. These regions offer a large patient pool and potential market demand for vaginal pessaries.
• Technological advancements: Continued research and development in the field of vaginal pessaries present opportunities for technological advancements. Innovations in design, materials, and manufacturing processes can lead to the development of more comfortable, effective, and patient-friendly pessaries. Advancements such as adjustable pessaries or those integrated with sensors for real-time monitoring could open up new possibilities and market segments.

Global Vaginal Pessary Market Trends:

• Shift towards non-surgical treatment options: Non-surgical therapy methods for pelvic organ prolapse and stress urine incontinence are becoming more popular. Vaginal pessaries, as a non-surgical intervention, are gaining popularity among patients and healthcare providers due to their effectiveness, safety, and non-invasiveness. This trend is driven by the desire to avoid surgical risks, reduce recovery time, and thus preserve natural anatomical structures.
• Growing focus on patient comfort and quality of life: Patient comfort and quality of life have become key considerations in the development and selection of vaginal pessaries. Manufacturers are prioritizing designs that offer improved comfort, reduced discomfort in wearing, and minimal interference with daily activities. Patient feedback and preferences are being incorporated into product development to enhance overall patient satisfaction.
• Rising demand for personalized treatment: There is an increasing demand for personalized treatment approaches in the vaginal pessary market. Patients and healthcare providers are recognizing the importance of customized pessaries to individual patient needs and anatomical requirements. Customizable pessaries that offer a range of sizes, shapes, and support levels are being developed to address this demand.

Global Vaginal Pessary Market Restraints:

• Product recalls: The increase in the number of product recalls by the regulatory authorities is expected to limit the market growth during forecast period. For instance, in February 2022, Cooper Surgical, Inc., a medical device company announced the class 2 device recall of Milex Gellhorn/Flexible ShortStem Pessary with & without kit. The reason behind the recall was the affected Milex Gellhorn pessaries that were incorrectly manufactured with a long stem (2.170), instead of a short stem (1.670 or 1.960 nominal height), as was required. The length discrepancy does not meet the released print dimensions.

Counterbalance: The manufacturing companies are expected to standardize the manufacturing and production processes of the medical devices to ensure product quality and stability.

• Patient compliance and discomfort: Achieving and maintaining patient compliance with pessary use can be challenging. Some patients may experience discomfort, irritation, or difficulty with insertion or removal, which can affect adherence to treatment. Addressing patient concerns, providing proper education and support, and offering a range of pessary options can help overcome these challenges.

Recent Developments

Company Acquisitions

• In February 2022, Cooper Companies, Inc. a medical device company manufacturing devices such as pessaries among others acquired Cook Medical's reproductive health division which is a manufacturer of minimally invasive medical devices focused on the fertility, obstetrics, and gynaecology industries.
• In September 2020, MedGyn Products, Inc., a global medical device company manufacturing vaginal pessaries among other products, acquired Thomas Medical, a medical device company that focuses on women’s health. This acquisition demonstrates MedGyn Products, Inc.'s strong commitment to both patients and healthcare professionals by continuing to provide dependable products and services in the field of women's healthcare.

Figure 2. Global Vaginal Pessary Market Share (%), By Product Type, 2023

To learn more about this report, request a free sample copy

Top Companies in Global Vaginal Pessary Market

• Cooper Companies, Inc.
• MedGyn Products, Inc.
• Milex Products, Inc.
• Personal Medical Corp.
• Panpac Medical Corp.
• Gyneas
• Integra LifeSciences
• Boston Scientific Corporation
• Coloplast Corp
• Bray Group Limited
• Marina Medical Instruments
• Bioteque America Inc.
• Sugar International
• for.me.sa.